ANDREA ROSIK: Open Payments
NPI 1063407955 · SHELBY TOWNSHIP, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$33,998 in 121 payments from 24 companies in 2025. Trend: 2023 $18,069 · 2024 $33,447 · 2025 $33,998
Grant: $20,000Speaker / faculty: $5,280Food & beverage: $3,455Honoraria: $3,250Consulting: $1,530Travel & lodging: $383
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $20,545 |
| GENZYME CORPORATION | 16 | $6,093 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $3,250 |
| LEO Pharma Inc. | 11 | $1,245 |
| UCB, Inc. | 6 | $1,024 |
| Janssen Biotech, Inc. | 12 | $263 |
| E.R. Squibb & Sons, L.L.C. | 6 | $224 |
| Galderma Laboratories, L.P. | 12 | $218 |
| Amgen Inc. | 8 | $208 |
| Arcutis Biotherapeutics, Inc. | 5 | $169 |
Products named: RINVOQ, DUPIXENT, Bimzelx, ANZUPGO, ADBRY, TREMFYA, Sotyktu, SKYRIZI.
Industry payments across MI — which companies pay providers there.
